αSMA+ fibroblasts suppress Lgr5+ cancer stem cells and restrain colorectal cancer progression

Oncogene ◽  
2021 ◽  
Author(s):  
Kathleen M. McAndrews ◽  
Karina Vázquez-Arreguín ◽  
Changsoo Kwak ◽  
Hikaru Sugimoto ◽  
Xiaofeng Zheng ◽  
...  
2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Xiao-Bing Wu ◽  
Yang Liu ◽  
Gui-Hua Wang ◽  
Xiao Xu ◽  
Yang Cai ◽  
...  

Gut ◽  
2012 ◽  
Vol 62 (4) ◽  
pp. 550-560 ◽  
Author(s):  
Astrid De Boeck ◽  
Patrick Pauwels ◽  
Karen Hensen ◽  
Jean-Luc Rummens ◽  
Wendy Westbroek ◽  
...  

2021 ◽  
Vol 18 (2) ◽  
pp. 171-183
Author(s):  
Alicja Zalewski ◽  
Adam E Snook ◽  
Scott A Waldman

Colorectal cancer continues to represent a significant burden on public health as the second highest cause of cancer mortality, when men and women are combined, in the US. About 50% of patients either present with late-stage metastatic disease, or develop metastatic recurrences, and ultimately die. In turn, this mortality largely reflects cancer stem cells, tumor-initiating cells that are responsible for cancer progression, drug resistance, recurrence and metastasis. This review summarizes the unique properties of colorectal cancer stem cells, and the emerging strategies by which they can be selectively targeted as a therapeutic approach to eradicating this disease.


2019 ◽  
Vol 10 (4) ◽  
Author(s):  
Gen Nishikawa ◽  
Kenji Kawada ◽  
Jun Nakagawa ◽  
Kosuke Toda ◽  
Ryotaro Ogawa ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document